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Every day physicians balance clinical information with
medical test results when confronted with symptomatic
patients. Sometimes they find themselves in an apparently
contradicting situation in which a patient has persistent
complaints while his or her medical tests are normal. In
this issue of the Netherlands Heart Journal, Yokota et al.
addressed this matter in the setting of stable angina pec-
toris [1]. The authors performed a retrospective analysis
of all patients who had undergone nuclear myocardial
perfusion imaging in their centre and selected those with
a normal scan but with persistent or worsening complaints
that compelled the treating physician to order an invasive
angiogram. Out of more than 11,000 patients, 229 fulfilled
the study criteria.
The authors reported that in this highly selected group of
patients a fairly high percentage (34%) had significant coro-
nary artery disease despite a normal perfusion scan, which
was defined as >50% stenosis in the left main coronary
artery or >70% stenosis for other segments. In the major-
ity of cases, it concerned single-vessel disease (60%), while
only a minority (17%) had left main coronary artery disease
or three-vessel disease. Coronary revascularisation was per-
formed in 90% and most of them were free of symptoms
after 7 years of follow-up. The authors found that older
age, male sex, typical angina and previous PCI are inde-
pendent predictors for the presence of severe stenosis on
invasive angiography following a normal myocardial perfu-
sion scan. As the study was conducted in a ‘pre-FFR era’
there was a low rate of invasive functional testing, which in
part might explain the discordancy.
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This study provides us with new insights on the diag-
nostic value of nuclear myocardial perfusion imaging and
refutes the common belief of balanced ischaemia (three-
vessel or left main coronary artery disease) as the rea-
son for false-negative perfusion scans. Assuming that the
scans were performed according to the modern technolog-
ical standards and known pitfalls as the use of xanthine
Fig. 1 A patient with a pre-test probability of disease of 70% who
undergoes a test with a sensitivity of 86% and a specificity of 72% will
have a post-test probability of disease of 32% in case of a negative test
and 88% with a positive test
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derivate were avoided, no other reason than a shortcoming
of the test itself can be put forward; no test is perfect.
Most importantly, this study shows the importance of as-
sessing the pre-test probability of disease in clinical prac-
tice. Looking at the patient characteristics of this highly se-
lected group, the authors examined a high-risk population,
which is also reflected in the 14% mortality after 7 years of
follow-up.
When a diagnostic test with a sensitivity between
85–90% and a specificity around 70% is employed in
this population, the reported ‘false-negative’ rate of 34%
is not surprising (Fig. 1; [2]). Patients with angina pectoris
and a high pre-test probability should be considered to
have significant coronary artery disease on forehand and
do not actually need further testing for the diagnosis itself.
Performing a non-invasive test in these patients is neverthe-
less sensible as it provides valuable prognostic information.
Patients with extensive ischaemia will benefit from a proac-
tive coronary revascularisation strategy while those with
a normal test can be treated with medical therapy [3].
There are sufficient data that show that a normal nuclear
myocardial perfusion scan is associated with a favourable
prognosis [4]. When complaints persist or worsen despite
appropriate medical therapy, further invasive testing should
be considered, especially in those with advanced age, male
gender or previous PCI as these are associated with high
risk, and a false-negative scan is very much possible.
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